利地安非他明是一种有效的单药治疗中度至重度暴食症

Clinical Research In Practice: The Journal of Team Hippocrates Pub Date : 2022-07-25 DOI:10.22237/crp/1656633660

Benjamin Young

{"title":"利地安非他明是一种有效的单药治疗中度至重度暴食症","authors":"Benjamin Young","doi":"10.22237/crp/1656633660","DOIUrl":null,"url":null,"abstract":"A clinical decision report using:\nMcElroy SL, Hudson J, Ferreira-Cornwell MC, Radewonuk J, Whitaker T, Gasior M. Lisdexamfetamine dimesylate for adults with moderate to severe binge eating disorder: Results of two pivotal phase 3 randomized controlled trials. Neuropsychopharmacology. 2016;41(5):1251-1260. https://doi.org/10.1038/npp.2015.275\nfor a young woman requesting a novel pharmacological intervention for a Binge Eating Disorder (BED).","PeriodicalId":10422,"journal":{"name":"Clinical Research In Practice: The Journal of Team Hippocrates","volume":"57 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Lisdexamfetamine is an effective monotherapy for moderate to severe binge eating disorder\",\"authors\":\"Benjamin Young\",\"doi\":\"10.22237/crp/1656633660\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A clinical decision report using:\\nMcElroy SL, Hudson J, Ferreira-Cornwell MC, Radewonuk J, Whitaker T, Gasior M. Lisdexamfetamine dimesylate for adults with moderate to severe binge eating disorder: Results of two pivotal phase 3 randomized controlled trials. Neuropsychopharmacology. 2016;41(5):1251-1260. https://doi.org/10.1038/npp.2015.275\\nfor a young woman requesting a novel pharmacological intervention for a Binge Eating Disorder (BED).\",\"PeriodicalId\":10422,\"journal\":{\"name\":\"Clinical Research In Practice: The Journal of Team Hippocrates\",\"volume\":\"57 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-07-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Research In Practice: The Journal of Team Hippocrates\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22237/crp/1656633660\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Research In Practice: The Journal of Team Hippocrates","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22237/crp/1656633660","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

McElroy SL, Hudson J, Ferreira-Cornwell MC, Radewonuk J, Whitaker T, gasor M.利地安非他明二磺酸酯治疗成人中度至重度暴食症的临床决策报告:两项关键的3期随机对照试验的结果。神经精神药理学。2016;41(5):1251 - 1260。https://doi.org/10.1038/npp.2015.275for一位年轻女性要求一种新的药物干预暴食症(BED)。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Lisdexamfetamine is an effective monotherapy for moderate to severe binge eating disorder

A clinical decision report using: McElroy SL, Hudson J, Ferreira-Cornwell MC, Radewonuk J, Whitaker T, Gasior M. Lisdexamfetamine dimesylate for adults with moderate to severe binge eating disorder: Results of two pivotal phase 3 randomized controlled trials. Neuropsychopharmacology. 2016;41(5):1251-1260. https://doi.org/10.1038/npp.2015.275 for a young woman requesting a novel pharmacological intervention for a Binge Eating Disorder (BED).

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Clinical Research In Practice: The Journal of Team Hippocrates

自引率

0.00%

发文量